Advertisement
BD Biosciences
BD Biosciences

The Scientist

» breast cancer

Most Recent

image: Bodybuilders Take Breast Cancer Drug

Bodybuilders Take Breast Cancer Drug

By | February 17, 2014

Tamoxifen, an endocrine therapy for women with breast cancer, is found in a supplement marketed to bodybuilders.

0 Comments

image: Top 10 Innovations 2013

Top 10 Innovations 2013

By | December 1, 2013

The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.

1 Comment

image: Decoding Breast Cancer Drug Resistance

Decoding Breast Cancer Drug Resistance

By | November 3, 2013

Common mutations in metastasized breast tumors suggest how the cancer can develop resistance to frontline drugs.

2 Comments

image: NFL Gear Yields Little for Cancer

NFL Gear Yields Little for Cancer

By | October 16, 2013

Only a small proportion of money made from breast cancer-themed football merchandise actually supports efforts to combat the disease.  

0 Comments

image: Contributors

Contributors

By | April 1, 2013

Meet some of the people featured in the April 2013 issue of The Scientist.

0 Comments

image: Cancer Gene Bonanza

Cancer Gene Bonanza

By | March 27, 2013

International collaboration doubles the number of genetic regions associated with breast, prostate, and ovarian cancers.

2 Comments

image: Cancer Research Advocate Dies

Cancer Research Advocate Dies

By | March 5, 2013

A champion of breast cancer awareness in the African-American community passes away at 63.

0 Comments

image: Little Cancer Risk from Fukushima

Little Cancer Risk from Fukushima

By | March 1, 2013

A new report from the World Health Organization predicts only very minimal increases in cancer risk for residents in the vicinity of the nuclear disaster.

0 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

Advertisement
Arbor Assays
Arbor Assays

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Lexogen
Lexogen
Advertisement
Life Technologies